Filing Flows › Comparisons › CAMP vs CTMX
Camp4 Therapeutics vs CytomX Therapeutics: CAMP and CTMX compared
Camp4 Therapeutics is the larger company: $1.9M of revenue in its latest quarter (Q3 2026) against $1.7M for CytomX Therapeutics (Q3 2026). Camp4 Therapeutics is growing faster (+139% against -72% a year earlier).
Where the money goes: CAMP and CTMX
Camp4 Therapeutics (CAMP) · Q3 2026
Camp4 Therapeutics, Q3 2026: revenue $1.9M (+139% year over year), operating margin -738.8%, net loss $29.0M, operating cash flow −$8.2M. The chart follows the revenue to costs, profit and cash.
CytomX Therapeutics (CTMX) · Q3 2026
CytomX Therapeutics, Q3 2026: revenue $1.7M (-72% year over year), net loss $20.0M, operating cash flow $16.6M. The chart follows the revenue to costs, profit and cash.
| Camp4 Therapeutics (CAMP) | CytomX Therapeutics (CTMX) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $1.9M | $1.7M |
| Revenue growth, Y/Y | +139% | -72% |
| Operating margin | -738.8% | n/m |
| Net earnings | −$29.0M | −$20.0M |
| Operating cash flow | −$8.2M | $16.6M |
| Free cash flow | — | $16.1M |
Questions
Which is bigger, Camp4 Therapeutics or CytomX Therapeutics?
Camp4 Therapeutics is the larger company: $1.9M of revenue in its latest quarter (Q3 2026) against $1.7M for CytomX Therapeutics (Q3 2026).
Is Camp4 Therapeutics or CytomX Therapeutics growing faster?
Camp4 Therapeutics is growing faster (+139% against -72% a year earlier).
More: Camp4 Therapeutics earnings · how Camp4 Therapeutics makes money · CytomX Therapeutics earnings · how CytomX Therapeutics makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 5, 2026; 10-Q filed Nov 5, 2026). Fiscal quarters can end on different dates. Not investment advice.